Nintedanib

Especificaciones

656247-17-5Número CAS

methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylateNombre IUPAC

C31H33N5O4Fórmula química

539.6 g/molPeso molecular

Nintedanib; 656247-17-5; Vargatef; Intedanib; BIBF-1120; 928326-83-4; BIBF 1120; BIBF1120; Nintedanib (BIBF 1120); 1160294-26-7; OFEV; MFCD11974012; (Z)-Methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; (Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; G6HRD2P839; Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate; methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate; C31H33N5O4; Nintedanib D3; 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester; methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate; Methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate; Ofev (TN); (Z)-Methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)-phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylidene)-2-oxo-2,3-dihydro-1h-indole-6-carboxylate; methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate; Nintedanib [INN]; Nintedanib E-isomer; Nintedanib [USAN]; Nintedanib [USAN:INN]; CID 9809715; UNII-G6HRD2P839; (E)-Nintedanib; 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)-; 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)- (9CI); BIBF 1120; Nintedanib; Ofev; Vargatef; Nintedanib (Standard); BIBF1120,Vargatef; Nintedanib (free base); INTEDANIB [MI]; Nintedanib (USAN/INN); BIBF1120 (Vargatef); NINTEDANIB [VANDF]; NINTEDANIB [WHO-DD]; BIBF 1120 (Nintedanib); MLS006010165; SCHEMBL431006; SCHEMBL431007; Nintedanib (BIBF 1120)?; US10669235, Nintedanib; GTPL5936; Nintedanib - Bio-X trade mark; orb1183654; orb1224326; orb1307463; SCHEMBL1535871; OFEV COMPONENT NINTEDANIB; CHEMBL2136735; SCHEMBL25226025; SCHEMBL29352914; CHEBI:85164; CHEBI:91413; HSDB 8339; DTXSID20918936; EX-A341; XZXHXSATPCNXJR-ZIADKAODSA-N; BDBM445209; BDBM734449; DTXSID201025948; GLXC-06034; HMS3244B06; HMS3244B10; HMS3244B14; HMS3295K01; HMS3654A05; HMS5079G03; EX-A2818; KWB29426; ZPC58784; ARD179559; BDBM50026612; EBC-11367; HY-50904R; NSC756659; NSC757442; NSC800805; s1010; AKOS005145820; AKOS025401745; AKOS026750205; CCG-264775; CS-0104; DB09079; FM34144; KS-1434; NSC-756659; NSC-757442; NSC-800805; SB11190; SDCCGSBI-0654257.P002; NCGC00263156-01; NCGC00263156-02; NCGC00263156-07; NCGC00263156-13; NCGC00263156-14; NCGC00263156-15; NCGC00389321-03; AC-25071; BN164249; BP-44034; HY-50904; methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenyl-methylene]-2-oxo-indoline-6-carboxylate; SMR004701273; SY034707; US20250129067, Compound Nintedanib; NS00040680; NS00099369; SW218301-2; D10481; EN300-188528; F050741; BRD-K49075727-001-01-0; BRD-K49075727-001-08-5; BRD-K49075727-001-09-3; Q15149723; Q27163267; Z2756516920; (3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]-amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid, methyl ester; (E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; 2,3-Dihydro-3[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester; 3-[[4-[methyl-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylic acid methyl ester; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone; Methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carb oxylate; Methyl (Z)-3-[[[4-[N-Methyl-2-(4-methyl-1-piperazinyl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate; Methyl 2-hydroxy-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-3H-indole-6-carboxylate; Methyl 2-hydroxy-3-[{4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]anilino}(phenyl)methylidene]-3H-indole-6-carboxylate; methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenyl-carbonimidoyl]-1H-indole-6-carboxylate; Methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; methyl 3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate; methyl 3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenyl-methylene]-2-oxo-indoline-6-carboxylateSinónimos